Gene Symbol | Gene ID | Gene Info |
---|---|---|
Junb
|
ENSMUSG00000052837.5 | jun B proto-oncogene |
Jund
|
ENSMUSG00000071076.5 | jun D proto-oncogene |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_84981077_84981273 | Junb | 2457 | 0.093985 | 0.38 | 4.8e-03 | Click! |
chr8_84978602_84979032 | Junb | 99 | 0.888996 | 0.32 | 1.6e-02 | Click! |
chr8_84981966_84982198 | Junb | 3364 | 0.076954 | 0.29 | 3.2e-02 | Click! |
chr8_84981723_84981874 | Junb | 3080 | 0.080788 | 0.26 | 5.4e-02 | Click! |
chr8_84982342_84982632 | Junb | 3769 | 0.072849 | 0.22 | 1.1e-01 | Click! |
chr8_70695184_70695683 | Jund | 3516 | 0.092066 | 0.25 | 6.7e-02 | Click! |
chr8_70691516_70692310 | Jund | 7036 | 0.075845 | -0.16 | 2.6e-01 | Click! |
chr8_70695802_70695953 | Jund | 3072 | 0.098412 | -0.11 | 4.3e-01 | Click! |
chr8_70698268_70700333 | Jund | 351 | 0.447242 | -0.05 | 7.2e-01 | Click! |
chr8_70696566_70697332 | Jund | 2000 | 0.132576 | 0.00 | 9.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14351950_14353283 | 318.76 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr14_14354416_14355184 | 69.73 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chr14_14353319_14353777 | 32.95 |
Il3ra |
interleukin 3 receptor, alpha chain |
3927 |
0.13 |
chr7_112678831_112680131 | 21.97 |
Tead1 |
TEA domain family member 1 |
29 |
0.91 |
chr6_146675264_146675472 | 19.34 |
4930479D17Rik |
RIKEN cDNA 4930479D17 gene |
18150 |
0.12 |
chr2_26139656_26141133 | 17.07 |
Tmem250-ps |
transmembrane protein 250, pseudogene |
127 |
0.93 |
chr3_146205393_146205616 | 16.94 |
Mcoln2 |
mucolipin 2 |
13421 |
0.17 |
chr12_54459580_54460031 | 16.89 |
Gm7557 |
predicted gene 7557 |
29407 |
0.13 |
chr15_38374820_38375240 | 16.01 |
Gm41307 |
predicted gene, 41307 |
29124 |
0.13 |
chr5_148645186_148645409 | 15.96 |
Gm29815 |
predicted gene, 29815 |
31653 |
0.15 |
chr11_117094306_117094534 | 15.52 |
Gm11730 |
predicted gene 11730 |
2607 |
0.15 |
chr16_22504977_22505156 | 15.13 |
9230117E06Rik |
RIKEN cDNA 9230117E06 gene |
6414 |
0.13 |
chr16_26316464_26316628 | 15.12 |
Cldn1 |
claudin 1 |
44248 |
0.19 |
chr5_122143714_122143881 | 14.61 |
Ccdc63 |
coiled-coil domain containing 63 |
2974 |
0.18 |
chr4_133928736_133928887 | 14.51 |
Hmgn2 |
high mobility group nucleosomal binding domain 2 |
38432 |
0.08 |
chr12_3238356_3238681 | 13.68 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
1907 |
0.28 |
chr10_120751937_120752288 | 13.41 |
Gm10743 |
predicted gene 10743 |
3779 |
0.15 |
chr7_123097743_123098471 | 13.38 |
Tnrc6a |
trinucleotide repeat containing 6a |
25778 |
0.17 |
chr8_45885259_45885494 | 13.25 |
Pdlim3 |
PDZ and LIM domain 3 |
85 |
0.96 |
chr4_134245189_134246001 | 13.20 |
Zfp593 |
zinc finger protein 593 |
3 |
0.93 |
chr4_40839300_40839457 | 13.14 |
Mir5123 |
microRNA 5123 |
10760 |
0.11 |
chr6_86831262_86831429 | 13.02 |
2610306M01Rik |
RIKEN cDNA 2610306M01 gene |
18095 |
0.12 |
chr5_134963701_134963852 | 12.98 |
Cldn4 |
claudin 4 |
16842 |
0.07 |
chr14_73014180_73014337 | 12.74 |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
11901 |
0.21 |
chr13_29609930_29611006 | 12.72 |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
93014 |
0.09 |
chr19_40247334_40247612 | 12.69 |
Pdlim1 |
PDZ and LIM domain 1 (elfin) |
16668 |
0.14 |
chr9_96752174_96752520 | 12.63 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
338 |
0.86 |
chr2_125470594_125470771 | 12.63 |
Gm9913 |
predicted gene 9913 |
34407 |
0.17 |
chr9_107259677_107259838 | 12.60 |
Mapkapk3 |
mitogen-activated protein kinase-activated protein kinase 3 |
2179 |
0.17 |
chr1_80218340_80218558 | 12.54 |
Fam124b |
family with sequence similarity 124, member B |
24 |
0.97 |
chr9_65247835_65247986 | 12.27 |
Cilp |
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase |
17270 |
0.11 |
chr5_123326532_123326683 | 12.25 |
Gm15860 |
predicted gene 15860 |
15292 |
0.08 |
chr4_155235382_155235584 | 12.24 |
Ski |
ski sarcoma viral oncogene homolog (avian) |
12891 |
0.15 |
chr14_14347096_14348750 | 12.16 |
Gm48860 |
predicted gene, 48860 |
659 |
0.44 |
chr15_102103278_102103879 | 12.15 |
Tns2 |
tensin 2 |
590 |
0.61 |
chr2_27813369_27813731 | 11.76 |
Col5a1 |
collagen, type V, alpha 1 |
72875 |
0.09 |
chr13_37666246_37666836 | 11.72 |
AI463229 |
expressed sequence AI463229 |
1 |
0.96 |
chr5_134959046_134959272 | 11.62 |
Cldn4 |
claudin 4 |
12225 |
0.07 |
chr8_57328239_57328807 | 11.60 |
5033428I22Rik |
RIKEN cDNA 5033428I22 gene |
3595 |
0.16 |
chr8_84197696_84198961 | 11.53 |
Gm26887 |
predicted gene, 26887 |
661 |
0.38 |
chr18_57674939_57675090 | 11.52 |
Gm26038 |
predicted gene, 26038 |
5456 |
0.19 |
chr15_96802479_96802683 | 11.51 |
Gm8888 |
predicted gene 8888 |
35503 |
0.18 |
chr1_180422474_180422792 | 11.47 |
Stum |
mechanosensory transduction mediator |
39979 |
0.1 |
chr14_25346108_25346275 | 11.43 |
Gm26660 |
predicted gene, 26660 |
32444 |
0.17 |
chr12_82225804_82226178 | 11.22 |
Sipa1l1 |
signal-induced proliferation-associated 1 like 1 |
30594 |
0.19 |
chr17_28176553_28177770 | 11.21 |
Zfp523 |
zinc finger protein 523 |
2 |
0.89 |
chr11_105905566_105905858 | 11.21 |
Tanc2 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
3729 |
0.17 |
chr2_74085114_74085265 | 11.19 |
A630050E04Rik |
RIKEN cDNA A630050E04 gene |
17153 |
0.2 |
chr5_150457278_150457429 | 11.17 |
Fry |
FRY microtubule binding protein |
358 |
0.8 |
chr1_75478602_75480080 | 11.15 |
Chpf |
chondroitin polymerizing factor |
34 |
0.68 |
chr14_69007423_69007574 | 11.12 |
Stc1 |
stanniocalcin 1 |
21740 |
0.18 |
chr3_96094270_96094598 | 11.11 |
Gm43554 |
predicted gene 43554 |
7563 |
0.1 |
chr6_86471867_86472650 | 11.00 |
C87436 |
expressed sequence C87436 |
8218 |
0.08 |
chr9_55264836_55265135 | 10.97 |
Nrg4 |
neuregulin 4 |
18587 |
0.16 |
chr3_98095099_98095437 | 10.89 |
Gm42820 |
predicted gene 42820 |
26320 |
0.16 |
chr2_35928205_35928411 | 10.89 |
Ttll11 |
tubulin tyrosine ligase-like family, member 11 |
12498 |
0.21 |
chr2_153161013_153161878 | 10.89 |
Tm9sf4 |
transmembrane 9 superfamily protein member 4 |
96 |
0.96 |
chr10_117042006_117042172 | 10.85 |
Gm10747 |
predicted gene 10747 |
1657 |
0.26 |
chr11_51343780_51343931 | 10.80 |
Col23a1 |
collagen, type XXIII, alpha 1 |
53935 |
0.11 |
chr16_20476945_20477183 | 10.74 |
Gm20615 |
predicted gene 20615 |
11724 |
0.1 |
chr17_12791535_12791805 | 10.73 |
Gm49959 |
predicted gene, 49959 |
10 |
0.96 |
chr5_123057752_123058346 | 10.71 |
Gm6444 |
predicted gene 6444 |
8193 |
0.09 |
chr17_29342302_29342489 | 10.57 |
Mtch1 |
mitochondrial carrier 1 |
535 |
0.64 |
chr14_54979086_54979402 | 10.57 |
Gm31251 |
predicted gene, 31251 |
149 |
0.85 |
chr8_24438713_24439074 | 10.48 |
Tcim |
transcriptional and immune response regulator |
91 |
0.96 |
chr10_42089464_42089625 | 10.41 |
Tdg-ps2 |
thymine DNA glycosylase, pseudogene 2 |
34238 |
0.18 |
chr15_59248986_59249144 | 10.39 |
Gm7691 |
predicted gene 7691 |
10576 |
0.17 |
chr18_67745899_67746216 | 10.30 |
Ptpn2 |
protein tyrosine phosphatase, non-receptor type 2 |
21462 |
0.13 |
chr11_89175642_89175967 | 10.28 |
Gm11497 |
predicted gene 11497 |
49098 |
0.12 |
chr13_95859005_95859156 | 10.28 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
32677 |
0.16 |
chr6_99931696_99931882 | 10.28 |
Gm44442 |
predicted gene, 44442 |
240 |
0.93 |
chr1_131003455_131003630 | 10.24 |
Il10 |
interleukin 10 |
16303 |
0.15 |
chr13_40939084_40939235 | 10.19 |
Gcnt2 |
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme |
7573 |
0.12 |
chr15_77022235_77022386 | 10.18 |
Mb |
myoglobin |
347 |
0.79 |
chr11_102219931_102220282 | 10.15 |
Hdac5 |
histone deacetylase 5 |
1177 |
0.29 |
chr19_46801626_46801777 | 10.08 |
Cnnm2 |
cyclin M2 |
40096 |
0.13 |
chr10_120872482_120872681 | 10.07 |
Msrb3 |
methionine sulfoxide reductase B3 |
1429 |
0.34 |
chr13_37446769_37446920 | 10.06 |
Gm29459 |
predicted gene 29459 |
4313 |
0.12 |
chr19_53740861_53741021 | 10.04 |
Gm16298 |
predicted gene 16298 |
27369 |
0.16 |
chr10_80621927_80622278 | 9.98 |
Csnk1g2 |
casein kinase 1, gamma 2 |
736 |
0.4 |
chr4_102510968_102511183 | 9.94 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
40678 |
0.21 |
chr16_38648302_38648489 | 9.88 |
Gm15530 |
predicted gene 15530 |
37474 |
0.12 |
chr2_76898947_76899098 | 9.86 |
Ttn |
titin |
9097 |
0.28 |
chr15_10831209_10831373 | 9.86 |
Gm19276 |
predicted gene, 19276 |
16464 |
0.21 |
chr13_53001599_53001812 | 9.81 |
Gm33424 |
predicted gene, 33424 |
14497 |
0.16 |
chr7_118475374_118475676 | 9.76 |
Gm44652 |
predicted gene 44652 |
4970 |
0.17 |
chr4_139481598_139481759 | 9.74 |
Ubr4 |
ubiquitin protein ligase E3 component n-recognin 4 |
1298 |
0.45 |
chr1_81725077_81725242 | 9.62 |
Gm5530 |
predicted gene 5530 |
17810 |
0.26 |
chr17_68165515_68165692 | 9.56 |
Gm49944 |
predicted gene, 49944 |
7953 |
0.22 |
chr18_55761914_55762508 | 9.54 |
Gm26959 |
predicted gene, 26959 |
15983 |
0.24 |
chr6_39725249_39725946 | 9.53 |
Braf |
Braf transforming gene |
134 |
0.96 |
chr15_79455490_79455785 | 9.51 |
Csnk1e |
casein kinase 1, epsilon |
71 |
0.95 |
chr10_21636718_21637002 | 9.48 |
1700020N01Rik |
RIKEN cDNA 1700020N01 gene |
20540 |
0.2 |
chr14_74871313_74871464 | 9.46 |
Lrch1 |
leucine-rich repeats and calponin homology (CH) domain containing 1 |
13867 |
0.22 |
chr14_69442998_69443617 | 9.45 |
Gm16867 |
predicted gene, 16867 |
16830 |
0.11 |
chr19_47512896_47513047 | 9.44 |
Gm19557 |
predicted gene, 19557 |
11 |
0.97 |
chr5_35019880_35020083 | 9.40 |
Rgs12 |
regulator of G-protein signaling 12 |
132 |
0.92 |
chr11_88467853_88468203 | 9.39 |
Gm11510 |
predicted gene 11510 |
34514 |
0.17 |
chr8_123477718_123478620 | 9.29 |
Afg3l1 |
AFG3-like AAA ATPase 1 |
229 |
0.77 |
chr1_180401862_180402062 | 9.26 |
Gm36933 |
predicted gene, 36933 |
25518 |
0.12 |
chr1_170699589_170699740 | 9.26 |
Gm23523 |
predicted gene, 23523 |
52159 |
0.1 |
chr7_30791378_30791529 | 9.25 |
Krtdap |
keratinocyte differentiation associated protein |
966 |
0.32 |
chr11_30161020_30161582 | 9.19 |
Sptbn1 |
spectrin beta, non-erythrocytic 1 |
36956 |
0.17 |
chrX_169996827_169997318 | 9.18 |
Gm15247 |
predicted gene 15247 |
10133 |
0.15 |
chr14_69661259_69661873 | 9.11 |
Gm27177 |
predicted gene 27177 |
16814 |
0.12 |
chr7_81134609_81135034 | 9.07 |
Slc28a1 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
19971 |
0.13 |
chr2_104525610_104525774 | 9.07 |
Gm13870 |
predicted gene 13870 |
11745 |
0.13 |
chr13_52987950_52988150 | 9.06 |
Nfil3 |
nuclear factor, interleukin 3, regulated |
6977 |
0.18 |
chr15_83535708_83535878 | 9.06 |
Bik |
BCL2-interacting killer |
2249 |
0.18 |
chr14_76302722_76302873 | 9.05 |
2900040C04Rik |
RIKEN cDNA 2900040C04 gene |
51340 |
0.14 |
chr14_23786365_23786526 | 9.03 |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
16859 |
0.27 |
chr7_112638999_112639150 | 9.03 |
Gm45473 |
predicted gene 45473 |
13708 |
0.16 |
chr6_138424907_138425582 | 9.03 |
Lmo3 |
LIM domain only 3 |
629 |
0.69 |
chr5_81832786_81832949 | 9.01 |
2900064F13Rik |
RIKEN cDNA 2900064F13 gene |
6051 |
0.24 |
chrY_90771156_90771656 | 8.94 |
Gm47283 |
predicted gene, 47283 |
13332 |
0.16 |
chr6_113644916_113645098 | 8.92 |
Gm43964 |
predicted gene, 43964 |
3486 |
0.09 |
chr4_11876139_11876309 | 8.90 |
Gm25002 |
predicted gene, 25002 |
72663 |
0.08 |
chr14_120313060_120313323 | 8.88 |
Mbnl2 |
muscleblind like splicing factor 2 |
6735 |
0.28 |
chr10_95778100_95778251 | 8.87 |
4732465J04Rik |
RIKEN cDNA 4732465J04 gene |
742 |
0.56 |
chr7_143395410_143395608 | 8.87 |
4933417O13Rik |
RIKEN cDNA 4933417O13 gene |
30884 |
0.11 |
chr16_44221614_44221765 | 8.85 |
Sidt1 |
SID1 transmembrane family, member 1 |
47843 |
0.12 |
chr5_45292445_45292780 | 8.84 |
Gm43303 |
predicted gene 43303 |
40683 |
0.15 |
chr10_93124320_93124535 | 8.84 |
Cdk17 |
cyclin-dependent kinase 17 |
36448 |
0.13 |
chr11_79339207_79339774 | 8.79 |
Nf1 |
neurofibromin 1 |
203 |
0.93 |
chr2_132106189_132106340 | 8.75 |
Slc23a2 |
solute carrier family 23 (nucleobase transporters), member 2 |
5184 |
0.18 |
chr11_120519847_120520008 | 8.67 |
Gm11789 |
predicted gene 11789 |
10627 |
0.06 |
chr5_114738758_114738938 | 8.64 |
Git2 |
GIT ArfGAP 2 |
2514 |
0.15 |
chr13_41729696_41729998 | 8.61 |
Adtrp |
androgen dependent TFPI regulating protein |
70719 |
0.08 |
chr1_125526055_125526324 | 8.61 |
Slc35f5 |
solute carrier family 35, member F5 |
34406 |
0.2 |
chr10_122966522_122966673 | 8.61 |
Mirlet7i |
microRNA let7i |
19127 |
0.16 |
chr17_26699875_26700026 | 8.60 |
Crebrf |
CREB3 regulatory factor |
15700 |
0.14 |
chr9_118762868_118763019 | 8.59 |
Itga9 |
integrin alpha 9 |
44341 |
0.15 |
chr5_134555506_134555722 | 8.59 |
Gm42884 |
predicted gene 42884 |
923 |
0.38 |
chr4_72379510_72379680 | 8.58 |
Gm11235 |
predicted gene 11235 |
163071 |
0.04 |
chr8_13063335_13063486 | 8.56 |
Proz |
protein Z, vitamin K-dependent plasma glycoprotein |
2445 |
0.15 |
chr16_95753314_95753465 | 8.56 |
Gm6599 |
predicted gene 6599 |
911 |
0.56 |
chr2_35302031_35302413 | 8.54 |
Stom |
stomatin |
18283 |
0.12 |
chr1_37971671_37971822 | 8.54 |
Lyg1 |
lysozyme G-like 1 |
13987 |
0.12 |
chr13_5714160_5714366 | 8.53 |
Gm35330 |
predicted gene, 35330 |
10179 |
0.27 |
chr9_56851829_56852274 | 8.52 |
Odf3l1 |
outer dense fiber of sperm tails 3-like 1 |
88 |
0.96 |
chr10_80141211_80141682 | 8.51 |
Atp5d |
ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit |
11 |
0.89 |
chr6_114818087_114818273 | 8.51 |
Gm44331 |
predicted gene, 44331 |
28790 |
0.14 |
chr6_29319072_29319245 | 8.51 |
Fam71f1 |
family with sequence similarity 71, member F1 |
1 |
0.96 |
chr11_78535469_78535809 | 8.44 |
Tnfaip1 |
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
632 |
0.35 |
chr14_69693425_69693591 | 8.43 |
Mir6950 |
microRNA 6950 |
1260 |
0.33 |
chr2_27774078_27774756 | 8.43 |
Rxra |
retinoid X receptor alpha |
34216 |
0.19 |
chr9_44135778_44135957 | 8.42 |
Mcam |
melanoma cell adhesion molecule |
677 |
0.37 |
chr4_140747973_140748298 | 8.42 |
Padi6 |
peptidyl arginine deiminase, type VI |
5492 |
0.13 |
chr6_6371774_6372069 | 8.37 |
Gm8652 |
predicted gene 8652 |
19654 |
0.17 |
chr7_45525718_45526561 | 8.37 |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
7 |
0.68 |
chr18_33373744_33373959 | 8.35 |
Gm5503 |
predicted gene 5503 |
11104 |
0.26 |
chr7_44405823_44406585 | 8.35 |
Gm45124 |
predicted gene 45124 |
19804 |
0.06 |
chr15_78844837_78845203 | 8.29 |
Cdc42ep1 |
CDC42 effector protein (Rho GTPase binding) 1 |
2396 |
0.14 |
chr9_121348136_121348306 | 8.28 |
Gm47092 |
predicted gene, 47092 |
1665 |
0.33 |
chr11_69965261_69965757 | 8.26 |
Cldn7 |
claudin 7 |
113 |
0.88 |
chr10_120915346_120915501 | 8.25 |
Gm16166 |
predicted gene 16166 |
12763 |
0.13 |
chr3_35693686_35693837 | 8.24 |
Gm6639 |
predicted gene 6639 |
27598 |
0.17 |
chr5_98935766_98935936 | 8.24 |
Prkg2 |
protein kinase, cGMP-dependent, type II |
7981 |
0.27 |
chr3_137980493_137981436 | 8.23 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
566 |
0.67 |
chr11_55021934_55022221 | 8.21 |
Anxa6 |
annexin A6 |
11338 |
0.16 |
chr1_16177628_16177794 | 8.14 |
Gm38249 |
predicted gene, 38249 |
32806 |
0.14 |
chr8_69192925_69193087 | 8.12 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
8781 |
0.15 |
chr1_89191429_89191580 | 8.08 |
Gm5259 |
predicted gene 5259 |
65477 |
0.11 |
chr14_54950252_54950403 | 8.08 |
Mir208a |
microRNA 208a |
1185 |
0.19 |
chr16_30828216_30828514 | 8.07 |
Gm26295 |
predicted gene, 26295 |
14203 |
0.14 |
chr16_26184716_26184995 | 8.05 |
P3h2 |
prolyl 3-hydroxylase 2 |
79071 |
0.11 |
chr4_156054432_156054595 | 8.05 |
Mir200a |
microRNA 200a |
472 |
0.37 |
chr15_63452659_63452810 | 8.04 |
Gm41335 |
predicted gene, 41335 |
26874 |
0.17 |
chr8_88633572_88633745 | 8.01 |
Snx20 |
sorting nexin 20 |
2443 |
0.26 |
chr16_10781913_10782082 | 8.00 |
Socs1 |
suppressor of cytokine signaling 1 |
3539 |
0.11 |
chr17_31855866_31856073 | 7.98 |
Sik1 |
salt inducible kinase 1 |
165 |
0.94 |
chr18_65120509_65120750 | 7.98 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
22929 |
0.21 |
chr14_21039181_21039332 | 7.96 |
Ap3m1 |
adaptor-related protein complex 3, mu 1 subunit |
12821 |
0.18 |
chr17_63678340_63678491 | 7.93 |
Gm9300 |
predicted gene 9300 |
24075 |
0.19 |
chr9_116223471_116223643 | 7.91 |
Gm31410 |
predicted gene, 31410 |
4755 |
0.21 |
chr6_83032753_83034325 | 7.90 |
Dok1 |
docking protein 1 |
68 |
0.86 |
chr15_96912277_96912440 | 7.89 |
Rpl10a-ps3 |
ribosomal protein L10A, pseudogene 3 |
11047 |
0.27 |
chr17_44203086_44203289 | 7.87 |
Clic5 |
chloride intracellular channel 5 |
14603 |
0.26 |
chr1_135731863_135732606 | 7.85 |
Csrp1 |
cysteine and glycine-rich protein 1 |
3087 |
0.22 |
chr2_49797881_49798044 | 7.82 |
Lypd6b |
LY6/PLAUR domain containing 6B |
10231 |
0.21 |
chr1_168382888_168383114 | 7.82 |
Gm38381 |
predicted gene, 38381 |
32193 |
0.18 |
chr11_17468975_17469133 | 7.75 |
Gm12016 |
predicted gene 12016 |
170129 |
0.03 |
chr16_38700536_38700687 | 7.73 |
Arhgap31 |
Rho GTPase activating protein 31 |
12287 |
0.14 |
chr8_126659831_126660263 | 7.72 |
Irf2bp2 |
interferon regulatory factor 2 binding protein 2 |
66061 |
0.11 |
chr17_34586512_34587397 | 7.71 |
Notch4 |
notch 4 |
9 |
0.91 |
chr7_66933267_66933575 | 7.62 |
Adamts17 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 17 |
23953 |
0.17 |
chr1_167802317_167803268 | 7.61 |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
113235 |
0.07 |
chr2_152734500_152735322 | 7.61 |
Id1 |
inhibitor of DNA binding 1, HLH protein |
1340 |
0.29 |
chr7_45277204_45277365 | 7.61 |
Slc6a21 |
solute carrier family 6 member 21 |
229 |
0.81 |
chr16_33337185_33337524 | 7.60 |
1700007L15Rik |
RIKEN cDNA 1700007L15 gene |
43321 |
0.13 |
chr11_114198299_114198666 | 7.57 |
1700092K14Rik |
RIKEN cDNA 1700092K14 gene |
224 |
0.93 |
chr6_88197240_88197577 | 7.53 |
Gata2 |
GATA binding protein 2 |
926 |
0.45 |
chr10_12046046_12046197 | 7.53 |
Gm48722 |
predicted gene, 48722 |
14681 |
0.21 |
chr4_105820475_105820710 | 7.48 |
Gm12728 |
predicted gene 12728 |
26373 |
0.25 |
chr7_136707362_136707939 | 7.45 |
Gm6249 |
predicted gene 6249 |
2954 |
0.34 |
chr6_37400778_37401412 | 7.42 |
Creb3l2 |
cAMP responsive element binding protein 3-like 2 |
41051 |
0.19 |
chr9_45201620_45201847 | 7.40 |
Tmprss4 |
transmembrane protease, serine 4 |
2253 |
0.17 |
chr11_65209272_65209759 | 7.39 |
Myocd |
myocardin |
4048 |
0.21 |
chr16_4500737_4500909 | 7.38 |
Srl |
sarcalumenin |
22240 |
0.15 |
chr11_98785795_98786170 | 7.38 |
Msl1 |
male specific lethal 1 |
9534 |
0.09 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 24.7 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
3.9 | 11.6 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
2.7 | 8.2 | GO:0048769 | sarcomerogenesis(GO:0048769) |
2.6 | 13.2 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
2.6 | 7.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.6 | 5.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.6 | 10.4 | GO:0030035 | microspike assembly(GO:0030035) |
2.6 | 7.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
2.4 | 4.8 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
2.4 | 7.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
2.3 | 9.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
2.1 | 8.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
2.1 | 4.2 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
2.0 | 12.0 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.8 | 5.5 | GO:0048320 | axial mesoderm formation(GO:0048320) |
1.8 | 5.4 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
1.8 | 7.1 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.7 | 8.5 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
1.7 | 6.7 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.6 | 6.6 | GO:0070836 | caveola assembly(GO:0070836) |
1.6 | 4.8 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
1.6 | 3.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
1.6 | 4.8 | GO:0003383 | apical constriction(GO:0003383) |
1.5 | 6.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
1.5 | 6.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
1.5 | 9.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.5 | 7.6 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
1.5 | 9.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
1.5 | 4.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.5 | 5.9 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.5 | 32.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
1.4 | 2.9 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.4 | 1.4 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
1.4 | 5.6 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
1.4 | 2.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.4 | 6.8 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
1.3 | 8.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
1.3 | 5.1 | GO:0030091 | protein repair(GO:0030091) |
1.3 | 5.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.3 | 6.3 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
1.2 | 3.7 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
1.2 | 4.7 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.2 | 3.5 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
1.1 | 4.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.1 | 4.5 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) |
1.1 | 7.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.1 | 4.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.1 | 4.2 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
1.1 | 10.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.1 | 3.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.0 | 9.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
1.0 | 3.1 | GO:0061074 | regulation of neural retina development(GO:0061074) |
1.0 | 2.0 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.0 | 4.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
1.0 | 7.8 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.9 | 2.8 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.9 | 2.7 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.9 | 5.4 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.9 | 2.7 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.9 | 0.9 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.9 | 3.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.9 | 5.3 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.9 | 8.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.9 | 4.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.9 | 0.9 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.9 | 1.7 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.9 | 4.4 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.9 | 3.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.9 | 6.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.9 | 0.9 | GO:0035973 | aggrephagy(GO:0035973) |
0.9 | 2.6 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.8 | 9.2 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.8 | 1.7 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.8 | 5.0 | GO:0060613 | fat pad development(GO:0060613) |
0.8 | 1.7 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.8 | 7.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.8 | 2.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.8 | 5.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.8 | 2.4 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.8 | 1.6 | GO:0090194 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.8 | 0.8 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.8 | 2.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.8 | 3.8 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.8 | 5.4 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.8 | 2.3 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.8 | 3.0 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.8 | 2.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.8 | 4.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.8 | 1.5 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.7 | 6.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.7 | 3.7 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.7 | 3.0 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.7 | 2.2 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.7 | 2.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.7 | 3.7 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.7 | 2.9 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.7 | 1.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.7 | 2.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.7 | 2.9 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.7 | 2.9 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.7 | 3.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.7 | 5.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.7 | 1.4 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.7 | 2.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 3.5 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.7 | 3.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.7 | 4.2 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.7 | 2.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.7 | 6.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.7 | 2.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.7 | 2.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.7 | 2.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.7 | 1.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.7 | 1.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.7 | 3.9 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.7 | 3.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.7 | 9.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.7 | 2.6 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.7 | 3.3 | GO:0035082 | axoneme assembly(GO:0035082) |
0.6 | 3.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.6 | 2.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.6 | 1.9 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.6 | 1.3 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.6 | 1.3 | GO:0046959 | habituation(GO:0046959) |
0.6 | 0.6 | GO:0072133 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.6 | 1.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.6 | 0.6 | GO:0032677 | regulation of interleukin-8 production(GO:0032677) |
0.6 | 1.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.6 | 1.8 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.6 | 1.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.6 | 0.6 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.6 | 1.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.6 | 1.2 | GO:0071335 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
0.6 | 1.8 | GO:0015889 | cobalamin transport(GO:0015889) |
0.6 | 1.2 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
0.6 | 1.2 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.6 | 0.6 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.6 | 2.3 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.6 | 3.5 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.6 | 4.6 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.6 | 1.2 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.6 | 6.3 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.6 | 3.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.6 | 1.1 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.6 | 2.9 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.6 | 4.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.6 | 1.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.6 | 2.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 3.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.6 | 1.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.6 | 1.7 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.6 | 12.1 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.5 | 0.5 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.5 | 1.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.5 | 1.6 | GO:0007296 | vitellogenesis(GO:0007296) |
0.5 | 2.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.5 | 4.4 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.5 | 1.6 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.5 | 0.5 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.5 | 0.5 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.5 | 1.1 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.5 | 2.2 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.5 | 2.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.5 | 10.8 | GO:0002021 | response to dietary excess(GO:0002021) |
0.5 | 2.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.5 | 4.3 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.5 | 2.7 | GO:0018101 | protein citrullination(GO:0018101) |
0.5 | 1.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.5 | 1.6 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.5 | 3.7 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.5 | 1.0 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.5 | 0.5 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.5 | 2.1 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.5 | 0.5 | GO:0070666 | negative regulation of mast cell apoptotic process(GO:0033026) mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.5 | 3.6 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.5 | 3.6 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.5 | 1.5 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.5 | 2.5 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.5 | 1.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.5 | 3.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.5 | 0.5 | GO:0051775 | response to redox state(GO:0051775) |
0.5 | 0.5 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.5 | 0.5 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.5 | 2.5 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.5 | 2.0 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.5 | 2.4 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.5 | 2.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.5 | 1.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.5 | 1.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.5 | 1.5 | GO:0000087 | mitotic M phase(GO:0000087) |
0.5 | 3.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 1.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.5 | 2.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.5 | 1.0 | GO:0006868 | glutamine transport(GO:0006868) |
0.5 | 5.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.5 | 1.4 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.5 | 4.8 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.5 | 1.4 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.5 | 1.9 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.5 | 1.4 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 0.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.5 | 0.9 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.5 | 1.9 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.5 | 0.9 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.5 | 2.8 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.5 | 0.9 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.5 | 1.9 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.5 | 2.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.5 | 5.0 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.5 | 0.5 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
0.5 | 1.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.5 | 1.8 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.5 | 1.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.5 | 1.4 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.5 | 1.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.5 | 8.2 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.5 | 4.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.4 | 0.9 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.4 | 2.7 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.4 | 4.9 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.4 | 0.9 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.4 | 0.9 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.4 | 0.4 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.4 | 0.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.4 | 1.3 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.4 | 4.8 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.4 | 0.9 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.4 | 1.7 | GO:0001842 | neural fold formation(GO:0001842) |
0.4 | 1.3 | GO:0035989 | tendon development(GO:0035989) |
0.4 | 1.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.4 | 0.4 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.4 | 1.7 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.4 | 0.4 | GO:0071800 | podosome assembly(GO:0071800) |
0.4 | 1.3 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.4 | 0.4 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.4 | 1.3 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.4 | 2.5 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.4 | 0.4 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.4 | 1.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.4 | 0.8 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.4 | 3.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.4 | 3.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.4 | 4.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.4 | 1.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.4 | 1.2 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.4 | 2.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.4 | 1.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 1.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 7.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.4 | 2.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.4 | 1.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.4 | 4.4 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.4 | 2.4 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.4 | 2.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.4 | 2.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.4 | 1.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 1.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.4 | 1.6 | GO:0015884 | folic acid transport(GO:0015884) |
0.4 | 2.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.4 | 0.8 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.4 | 1.5 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.4 | 1.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.4 | 10.0 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.4 | 5.0 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.4 | 1.5 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.4 | 5.4 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.4 | 2.3 | GO:0001553 | luteinization(GO:0001553) |
0.4 | 2.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.4 | 1.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.4 | 1.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.4 | 3.8 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 3.0 | GO:0090197 | positive regulation of chemokine secretion(GO:0090197) |
0.4 | 2.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.4 | 0.8 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.4 | 1.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.4 | 1.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.4 | 5.2 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.4 | 1.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.4 | 3.3 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 1.5 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.4 | 1.5 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.4 | 0.4 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.4 | 3.7 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 0.7 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.4 | 2.6 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.4 | 1.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.4 | 1.8 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.4 | 7.7 | GO:0035329 | hippo signaling(GO:0035329) |
0.4 | 2.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.4 | 1.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.4 | 4.0 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.4 | 0.7 | GO:0001757 | somite specification(GO:0001757) |
0.4 | 0.7 | GO:0002432 | granuloma formation(GO:0002432) |
0.4 | 0.7 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.4 | 2.8 | GO:0002076 | osteoblast development(GO:0002076) |
0.4 | 0.4 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.4 | 1.8 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.4 | 1.1 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.4 | 3.5 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.4 | 1.8 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.4 | 2.1 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.3 | 2.1 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.3 | 1.7 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.3 | 0.7 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.3 | 1.4 | GO:0031033 | myosin filament organization(GO:0031033) |
0.3 | 3.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.3 | 2.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 0.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 5.5 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.3 | 0.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 13.9 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.3 | 0.7 | GO:1903421 | positive regulation of synaptic vesicle transport(GO:1902805) regulation of synaptic vesicle recycling(GO:1903421) |
0.3 | 1.7 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 1.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.3 | 3.0 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.3 | 3.0 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.3 | 1.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 2.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 0.7 | GO:0008050 | female courtship behavior(GO:0008050) |
0.3 | 0.7 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.3 | 1.0 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.3 | 3.3 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.3 | 1.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.3 | 2.6 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.3 | 0.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 1.0 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.3 | 1.3 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.3 | 1.0 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.3 | 1.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.3 | 0.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.3 | 1.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 0.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.3 | 1.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 0.3 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.3 | 0.9 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.3 | 1.2 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.3 | 0.3 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.3 | 2.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.3 | 1.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.3 | 2.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.3 | 0.6 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.3 | 5.2 | GO:0060612 | adipose tissue development(GO:0060612) |
0.3 | 0.3 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.3 | 0.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.3 | 1.5 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.3 | 0.3 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.3 | 0.9 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 | 0.3 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.3 | 1.2 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.3 | 0.6 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.3 | 3.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.3 | 0.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.3 | 0.6 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.3 | 0.9 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.3 | 2.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.3 | 0.3 | GO:0007494 | midgut development(GO:0007494) |
0.3 | 0.9 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.3 | 3.0 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.3 | 0.6 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.3 | 4.4 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.3 | 2.6 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.3 | 4.7 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.3 | 0.9 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.3 | 0.9 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 1.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.3 | 0.9 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 | 1.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.3 | 1.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.3 | 1.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.3 | 1.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.3 | 0.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.3 | 0.3 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.3 | 8.0 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.3 | 0.9 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.3 | 1.7 | GO:0035878 | nail development(GO:0035878) |
0.3 | 0.8 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.3 | 0.6 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 0.8 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.3 | 1.1 | GO:0045978 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.3 | 0.8 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.3 | 2.8 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.3 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 2.5 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.3 | 0.8 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.3 | 0.8 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.3 | 0.6 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) |
0.3 | 0.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 1.1 | GO:0018214 | protein carboxylation(GO:0018214) |
0.3 | 0.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.3 | 5.3 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.3 | 0.3 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.3 | 1.4 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.3 | 0.8 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.3 | 0.8 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 0.6 | GO:1903798 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.3 | 0.6 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.3 | 0.3 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.3 | 0.8 | GO:0006848 | pyruvate transport(GO:0006848) |
0.3 | 0.5 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 0.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.3 | 0.8 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 1.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.3 | 0.5 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.3 | 0.8 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.3 | 0.3 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.3 | 0.8 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 0.3 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.3 | 0.3 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.3 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.3 | 0.5 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.3 | 2.1 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.3 | 0.3 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.3 | 7.3 | GO:0042073 | intraciliary transport(GO:0042073) |
0.3 | 1.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.3 | 0.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.3 | 0.8 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.3 | 1.3 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.3 | 0.8 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.3 | 2.0 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.3 | 0.5 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 0.8 | GO:0044794 | positive regulation by host of viral process(GO:0044794) positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 1.3 | GO:0007614 | short-term memory(GO:0007614) |
0.3 | 1.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 0.3 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.3 | 1.0 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.3 | 0.5 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.3 | 0.5 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.3 | 2.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 1.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.5 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 1.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 2.5 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 1.2 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 3.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 1.7 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 0.5 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.2 | 1.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.7 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 1.2 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.2 | 1.2 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 0.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.5 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.5 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.2 | 0.2 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.2 | 1.0 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.7 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.2 | 0.7 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 1.2 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
0.2 | 1.6 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.2 | 0.7 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.2 | 1.4 | GO:0002385 | mucosal immune response(GO:0002385) |
0.2 | 0.2 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.2 | 0.2 | GO:0009180 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.2 | 0.5 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.2 | 1.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 0.5 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 1.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.9 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.7 | GO:0031103 | axon regeneration(GO:0031103) |
0.2 | 0.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 2.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.2 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.2 | 0.9 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.9 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 1.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 0.2 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 0.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 1.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.2 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.2 | 0.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 0.4 | GO:0042637 | catagen(GO:0042637) |
0.2 | 0.2 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.2 | 0.9 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 1.5 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.2 | 1.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.7 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 0.4 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 0.4 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.2 | 0.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.2 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.2 | 0.4 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 1.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 0.6 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.2 | 1.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.2 | GO:0045073 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 0.9 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.2 | 0.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.2 | 0.2 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.2 | 2.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 1.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 2.7 | GO:0051923 | sulfation(GO:0051923) |
0.2 | 0.4 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.2 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 0.8 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.2 | 1.0 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 1.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 1.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 0.6 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 2.5 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.8 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 1.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.4 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 3.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 0.4 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.2 | 0.2 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.2 | 0.4 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 0.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 1.4 | GO:0072576 | liver morphogenesis(GO:0072576) |
0.2 | 1.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.2 | 0.4 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 1.0 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.4 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 0.6 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 0.4 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.2 | 4.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 0.8 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 1.8 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 1.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.2 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.2 | 0.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 1.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 0.2 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 0.2 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.2 | 0.6 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.2 | 0.8 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 0.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 0.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 2.4 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.2 | 0.4 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 3.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.2 | 0.2 | GO:0031280 | negative regulation of cyclase activity(GO:0031280) |
0.2 | 1.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 0.2 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
0.2 | 1.4 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.2 | 0.8 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.2 | 0.6 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.2 | 2.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.4 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.2 | 0.8 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 0.8 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 1.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 1.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.2 | 1.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.8 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.2 | 0.6 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 2.4 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.2 | 0.6 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 0.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.2 | GO:0072038 | mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
0.2 | 0.9 | GO:0060039 | pericardium development(GO:0060039) |
0.2 | 0.5 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.2 | 0.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 2.0 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 0.9 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 0.9 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.2 | 0.9 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 1.6 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.2 | 0.4 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.2 | 0.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.2 | 2.3 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.2 | 0.4 | GO:0007512 | adult heart development(GO:0007512) |
0.2 | 0.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.9 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 1.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 0.2 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.2 | 0.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 0.4 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 0.5 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.2 | 0.5 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 1.2 | GO:0003094 | glomerular filtration(GO:0003094) |
0.2 | 1.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.2 | 0.4 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.2 | 1.6 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.2 | 0.7 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 0.2 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.2 | 0.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.7 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 0.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 1.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 1.2 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 0.5 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 1.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.3 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.2 | 0.3 | GO:0051176 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of sulfur metabolic process(GO:0051176) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.2 | 0.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 1.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 3.7 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.2 | 16.8 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.2 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.7 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 1.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.5 | GO:0000303 | response to superoxide(GO:0000303) |
0.2 | 1.3 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.2 | 0.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.2 | 0.5 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 1.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 1.6 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.2 | 0.7 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.2 | 0.2 | GO:0015817 | histidine transport(GO:0015817) |
0.2 | 0.3 | GO:0097484 | dendrite extension(GO:0097484) |
0.2 | 0.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 0.3 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.2 | 0.8 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 0.8 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.2 | 1.0 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.2 | 0.5 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.2 | 0.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.3 | GO:0006573 | valine metabolic process(GO:0006573) |
0.2 | 0.5 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 0.2 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.2 | 0.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 0.8 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.2 | 1.1 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.2 | 0.5 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.2 | 0.3 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.2 | 0.6 | GO:1900543 | negative regulation of purine nucleotide metabolic process(GO:1900543) |
0.2 | 2.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 2.2 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.2 | 0.8 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.2 | 0.9 | GO:0060896 | neural plate pattern specification(GO:0060896) |
0.2 | 0.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.2 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.2 | 0.2 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.2 | 0.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 0.8 | GO:0032530 | regulation of microvillus organization(GO:0032530) |
0.2 | 0.2 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.2 | 0.3 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 0.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.2 | 0.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 0.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 1.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 0.3 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.2 | 0.9 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 0.3 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.2 | 0.6 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 0.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 5.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 0.6 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 0.5 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.2 | 0.6 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 0.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.4 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.1 | 0.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.3 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
0.1 | 0.6 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 1.8 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.1 | 0.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.1 | 2.3 | GO:0031279 | regulation of cyclase activity(GO:0031279) |
0.1 | 0.4 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 1.6 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 0.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.4 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.1 | 0.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.7 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.3 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.1 | 0.9 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.4 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.6 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.1 | 0.4 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.1 | 1.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.1 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.8 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.3 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.1 | 1.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 1.2 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 0.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.1 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.4 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 1.0 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.4 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 0.8 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.8 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.1 | GO:0003266 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
0.1 | 0.4 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.5 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.1 | 0.8 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.5 | GO:0051352 | negative regulation of ligase activity(GO:0051352) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.3 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.1 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.3 | GO:0048546 | digestive tract morphogenesis(GO:0048546) |
0.1 | 0.9 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.1 | 0.3 | GO:0048678 | response to axon injury(GO:0048678) |
0.1 | 2.9 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.4 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 1.4 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 0.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.4 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.1 | 0.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.5 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.4 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 2.5 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.1 | 0.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.1 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.1 | 1.1 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.1 | 0.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.4 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.1 | 0.6 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.1 | 0.5 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.8 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.4 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 0.7 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.6 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.6 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.7 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 0.1 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.5 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.9 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.4 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.1 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.1 | 0.5 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.1 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.4 | GO:0070723 | response to cholesterol(GO:0070723) |
0.1 | 1.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.1 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) |
0.1 | 0.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.2 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 1.0 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.5 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 2.4 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.2 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.6 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 2.8 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 3.1 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.1 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 0.3 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.7 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.3 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 1.6 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.1 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.1 | 0.4 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.1 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.4 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.1 | GO:0034123 | positive regulation of toll-like receptor signaling pathway(GO:0034123) |
0.1 | 0.9 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.4 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.1 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.3 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 1.1 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 0.8 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.1 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.1 | 0.7 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.2 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.5 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.3 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 1.9 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.2 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.1 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 1.2 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.5 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.1 | 1.1 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.8 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 0.6 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 0.6 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 1.9 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 1.5 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 1.6 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.1 | 2.0 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.2 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.1 | 0.2 | GO:0019081 | viral translation(GO:0019081) viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.1 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.1 | 0.7 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.1 | 0.2 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.1 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.1 | 0.1 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.1 | 0.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.1 | 0.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.7 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.3 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.2 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.1 | 0.1 | GO:0046271 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.2 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 0.1 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.1 | 4.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 0.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.4 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 1.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.2 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.1 | 0.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 1.1 | GO:0030510 | regulation of BMP signaling pathway(GO:0030510) |
0.1 | 0.2 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.3 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 3.0 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.9 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.3 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.7 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.3 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.1 | 0.3 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
0.1 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 1.2 | GO:0032612 | interleukin-1 production(GO:0032612) |
0.1 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 1.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.1 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.1 | 0.3 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.1 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.1 | 0.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.4 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 1.7 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.1 | 0.6 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.4 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.1 | 0.4 | GO:0071709 | membrane assembly(GO:0071709) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.4 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 0.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.3 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.1 | GO:0003171 | atrioventricular valve development(GO:0003171) |
0.1 | 0.2 | GO:0044259 | multicellular organismal macromolecule metabolic process(GO:0044259) |
0.1 | 0.3 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.3 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.3 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.1 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.1 | 0.1 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.1 | 0.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 0.2 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.1 | 0.2 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 0.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.5 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.1 | 0.4 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.1 | GO:0060914 | heart formation(GO:0060914) |
0.1 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.2 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.4 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.8 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 0.1 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.7 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.6 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 2.3 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.7 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.4 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.2 | GO:0042454 | ribonucleoside catabolic process(GO:0042454) |
0.1 | 0.6 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.8 | GO:0060389 | pathway-restricted SMAD protein phosphorylation(GO:0060389) |
0.1 | 0.8 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.4 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.4 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.4 | GO:0055024 | regulation of cardiac muscle tissue development(GO:0055024) |
0.1 | 0.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.3 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.1 | 0.6 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.7 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 0.2 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.1 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.1 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.6 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.1 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 0.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.4 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.1 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.1 | 1.1 | GO:0060606 | tube closure(GO:0060606) |
0.1 | 0.2 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
0.1 | 0.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 1.1 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.4 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.1 | 0.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.6 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 1.0 | GO:0060840 | artery development(GO:0060840) |
0.1 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.3 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.3 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.1 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.1 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.1 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.1 | 0.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 1.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.1 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.1 | 0.5 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.1 | GO:0046958 | nonassociative learning(GO:0046958) |
0.1 | 0.4 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.1 | GO:1900746 | vascular endothelial growth factor signaling pathway(GO:0038084) regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.1 | 0.8 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.1 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.2 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
0.1 | 0.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.1 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.1 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 1.5 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.2 | GO:1902745 | positive regulation of lamellipodium organization(GO:1902745) |
0.1 | 0.1 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.1 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 0.6 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.1 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.1 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 1.2 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 1.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.1 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 0.1 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.1 | 0.3 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.1 | 0.5 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 0.2 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.3 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 | 0.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.1 | 0.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.8 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.5 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.4 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.1 | 0.3 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.1 | 0.5 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.2 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) |
0.1 | 0.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.1 | GO:0051029 | rRNA export from nucleus(GO:0006407) rRNA transport(GO:0051029) |
0.1 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.2 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.1 | 0.2 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 0.4 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.0 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.0 | 0.0 | GO:1903578 | regulation of nucleoside metabolic process(GO:0009118) regulation of ATP metabolic process(GO:1903578) |
0.0 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.0 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.2 | GO:0060688 | regulation of morphogenesis of a branching structure(GO:0060688) |
0.0 | 0.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.2 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.0 | 0.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.0 | 0.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.5 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.0 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.5 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.0 | 0.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.0 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.0 | 0.1 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) positive regulation of sister chromatid cohesion(GO:0045876) |
0.0 | 0.1 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.0 | 0.1 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.0 | 0.8 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.0 | 0.7 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.0 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.2 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.0 | 0.0 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.0 | 0.0 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.5 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.0 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.0 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.5 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.0 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.2 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.0 | 0.1 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.0 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.0 | 0.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.1 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.8 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.0 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.0 | 0.6 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
0.0 | 0.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.1 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.0 | 0.5 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.1 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.0 | 0.2 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 1.1 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.0 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
0.0 | 0.0 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.0 | 0.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.2 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.0 | 0.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.0 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.0 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.0 | 0.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.1 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.2 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.0 | 0.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.0 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.0 | 0.0 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 0.1 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.0 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.0 | GO:1902075 | cellular response to salt(GO:1902075) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.3 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.0 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.0 | 0.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.0 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.0 | 0.2 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
0.0 | 0.1 | GO:0045078 | regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 0.0 | GO:0060594 | mammary gland specification(GO:0060594) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.2 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.0 | 0.1 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.0 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.5 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.0 | 0.6 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.0 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.4 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.2 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.0 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 1.8 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.0 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.0 | 0.0 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.6 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.0 | 0.6 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.3 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.2 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.0 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 34.1 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.2 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.0 | 0.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 0.6 | GO:0071774 | response to fibroblast growth factor(GO:0071774) |
0.0 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.0 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.5 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
0.0 | 0.2 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.0 | 0.0 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.0 | 0.0 | GO:0019230 | proprioception(GO:0019230) |
0.0 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.0 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.0 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.0 | 0.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.0 | 0.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.0 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.0 | 0.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.1 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.0 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.0 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.0 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.0 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.0 | 0.1 | GO:0071467 | cellular response to pH(GO:0071467) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
0.0 | 0.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.0 | GO:0045117 | azole transport(GO:0045117) |
0.0 | 0.0 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.0 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.0 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.0 | 0.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.0 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.0 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.0 | 0.0 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.0 | GO:0010573 | vascular endothelial growth factor production(GO:0010573) |
0.0 | 0.1 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 0.2 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.0 | 0.0 | GO:0070627 | ferrous iron import(GO:0070627) |
0.0 | 0.0 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.0 | 0.1 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.0 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.0 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.0 | GO:1902402 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.0 | GO:0033032 | regulation of myeloid cell apoptotic process(GO:0033032) |
0.0 | 0.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.0 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.0 | 0.0 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.0 | 0.0 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.0 | 0.0 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.0 | 0.2 | GO:0007530 | sex determination(GO:0007530) |
0.0 | 0.0 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.0 | 0.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.0 | 0.0 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.0 | 0.1 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.2 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.0 | 0.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.0 | 0.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.3 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.0 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.0 | GO:0003230 | cardiac atrium development(GO:0003230) |
0.0 | 0.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.0 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.2 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.0 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.0 | 0.0 | GO:0046782 | regulation of viral transcription(GO:0046782) |
0.0 | 0.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.0 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.1 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 0.2 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.0 | 0.0 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.0 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.0 | 0.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.0 | 0.0 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.0 | 0.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.0 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.0 | 0.0 | GO:0042476 | odontogenesis(GO:0042476) |
0.0 | 2.2 | GO:0052547 | regulation of peptidase activity(GO:0052547) |
0.0 | 0.0 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.0 | 0.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.0 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.0 | 0.0 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 | 0.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.0 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.0 | 0.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.3 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.0 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.0 | 0.1 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.0 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.0 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.0 | 0.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.0 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 2.2 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.0 | 0.0 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.0 | 0.0 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.0 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.0 | 0.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.0 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.0 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.0 | GO:0086011 | membrane repolarization during action potential(GO:0086011) |
0.0 | 0.0 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.4 | GO:0044393 | microspike(GO:0044393) |
2.4 | 7.2 | GO:0005745 | m-AAA complex(GO:0005745) |
2.2 | 9.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.9 | 5.7 | GO:1990423 | RZZ complex(GO:1990423) |
1.5 | 7.3 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.4 | 24.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.3 | 5.1 | GO:0035339 | SPOTS complex(GO:0035339) |
1.3 | 3.8 | GO:0097513 | myosin II filament(GO:0097513) |
1.2 | 3.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.1 | 6.7 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.0 | 5.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.0 | 3.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.0 | 5.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.0 | 2.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.0 | 16.5 | GO:0097440 | apical dendrite(GO:0097440) |
1.0 | 11.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.9 | 3.7 | GO:0070545 | PeBoW complex(GO:0070545) |
0.9 | 7.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.9 | 4.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.9 | 3.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.8 | 6.8 | GO:0005861 | troponin complex(GO:0005861) |
0.8 | 2.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.8 | 3.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.8 | 9.8 | GO:0036038 | MKS complex(GO:0036038) |
0.7 | 8.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.7 | 4.5 | GO:0043219 | lateral loop(GO:0043219) |
0.7 | 3.7 | GO:0070820 | tertiary granule(GO:0070820) |
0.7 | 5.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.7 | 8.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.7 | 2.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.7 | 2.7 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.7 | 5.9 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.6 | 1.9 | GO:0071953 | elastic fiber(GO:0071953) |
0.6 | 5.0 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.6 | 7.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.6 | 10.3 | GO:0002102 | podosome(GO:0002102) |
0.6 | 3.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.6 | 3.6 | GO:0002177 | manchette(GO:0002177) |
0.6 | 0.6 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.6 | 1.8 | GO:0032437 | cuticular plate(GO:0032437) |
0.6 | 6.3 | GO:0001527 | microfibril(GO:0001527) |
0.6 | 3.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.6 | 12.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.6 | 2.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.6 | 2.8 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.6 | 1.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.5 | 0.5 | GO:0000125 | PCAF complex(GO:0000125) |
0.5 | 1.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 2.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.5 | 2.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 0.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.5 | 2.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.5 | 1.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.5 | 1.9 | GO:0044308 | axonal spine(GO:0044308) |
0.5 | 1.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 6.3 | GO:0036379 | myofilament(GO:0036379) |
0.4 | 1.8 | GO:0071203 | WASH complex(GO:0071203) |
0.4 | 4.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 0.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 1.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 1.7 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.4 | 1.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.4 | 3.0 | GO:0045179 | apical cortex(GO:0045179) |
0.4 | 0.8 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.4 | 2.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 2.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 0.8 | GO:0032280 | symmetric synapse(GO:0032280) |
0.4 | 0.8 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.4 | 4.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 4.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.4 | 3.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.4 | 3.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 1.8 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.4 | 4.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 3.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.4 | 1.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 3.9 | GO:0070852 | cell body fiber(GO:0070852) |
0.4 | 0.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 1.4 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 3.1 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 1.4 | GO:0035363 | histone locus body(GO:0035363) |
0.3 | 2.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 5.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 1.0 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 1.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 0.3 | GO:0036452 | ESCRT III complex(GO:0000815) ESCRT complex(GO:0036452) |
0.3 | 1.3 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 0.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 1.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 1.0 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 1.0 | GO:0043205 | fibril(GO:0043205) |
0.3 | 2.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.3 | 1.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.3 | 2.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 2.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 0.9 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.3 | 1.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.3 | 95.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.3 | 1.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 2.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 4.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 3.3 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.3 | 2.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 3.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 1.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 2.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 90.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 1.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 1.9 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 0.3 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.3 | 1.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 1.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 24.9 | GO:0043296 | apical junction complex(GO:0043296) |
0.3 | 2.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 5.6 | GO:0000786 | nucleosome(GO:0000786) |
0.3 | 0.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 0.8 | GO:0035061 | interchromatin granule(GO:0035061) |
0.3 | 1.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 9.7 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.7 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 1.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.2 | 2.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.2 | 2.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 0.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 0.5 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 1.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 1.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 1.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 5.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 0.5 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.2 | 5.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 0.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 2.0 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 0.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 1.7 | GO:0031674 | I band(GO:0031674) |
0.2 | 0.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 1.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 1.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 2.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 0.6 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 0.6 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 5.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 2.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 1.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 3.0 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 1.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 13.8 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 3.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 1.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 0.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 0.9 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 1.1 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 7.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.3 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.2 | 1.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 2.2 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 0.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 0.5 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 0.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 1.0 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 1.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 1.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 0.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 0.7 | GO:0031430 | M band(GO:0031430) |
0.2 | 9.5 | GO:0030018 | Z disc(GO:0030018) |
0.2 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 1.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 2.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 1.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 15.6 | GO:0005903 | brush border(GO:0005903) |
0.2 | 0.3 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 1.4 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 13.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 0.9 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 9.3 | GO:0042383 | sarcolemma(GO:0042383) |
0.2 | 1.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 0.8 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 3.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.4 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.1 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.1 | 1.3 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 2.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 1.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 0.8 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 1.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 5.5 | GO:0005911 | cell-cell junction(GO:0005911) |
0.1 | 0.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.3 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.6 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 5.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.6 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.6 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 3.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 2.6 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 0.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 1.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.6 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.6 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.1 | 0.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.3 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.6 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 1.7 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 1.5 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.5 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.8 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.9 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 1.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 7.8 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 1.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.3 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 4.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 5.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 1.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.4 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.4 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 1.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.8 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 2.1 | GO:0005844 | polysome(GO:0005844) |
0.1 | 1.1 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.7 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.6 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.4 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.8 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 2.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 1.7 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 6.7 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 1.6 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.3 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.1 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 0.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.8 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.1 | 0.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 1.0 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 1.1 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 1.2 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 1.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.7 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 1.0 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.5 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 2.1 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.0 | 7.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.9 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.0 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.2 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 1.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 1.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.3 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.0 | 0.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 24.9 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 2.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.0 | 0.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 1.5 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.4 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.0 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 0.3 | GO:1990752 | microtubule end(GO:1990752) |
0.0 | 1.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.0 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.0 | GO:1904949 | ATPase complex(GO:1904949) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.4 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 0.0 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 0.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.5 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.0 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 21.7 | GO:0005576 | extracellular region(GO:0005576) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
2.7 | 11.0 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
2.0 | 6.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.8 | 5.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.8 | 1.8 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
1.5 | 7.6 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.4 | 10.0 | GO:0045545 | syndecan binding(GO:0045545) |
1.4 | 5.6 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.4 | 8.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.4 | 4.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.3 | 3.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.3 | 5.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.3 | 3.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.3 | 3.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.3 | 5.1 | GO:0031433 | telethonin binding(GO:0031433) |
1.3 | 10.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
1.2 | 3.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.2 | 3.5 | GO:0051373 | FATZ binding(GO:0051373) |
1.1 | 15.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.1 | 5.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.1 | 3.2 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
1.1 | 10.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
1.0 | 8.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.0 | 8.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.0 | 4.1 | GO:0031013 | troponin I binding(GO:0031013) |
1.0 | 3.9 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
1.0 | 2.9 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
1.0 | 2.9 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.0 | 6.7 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.9 | 2.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.9 | 7.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.9 | 5.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.9 | 2.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.9 | 6.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.9 | 2.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.8 | 5.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.8 | 2.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.8 | 4.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.8 | 4.9 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.8 | 8.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.8 | 5.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.8 | 2.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.8 | 10.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.8 | 3.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.8 | 4.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.8 | 0.8 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.8 | 3.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.7 | 7.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.7 | 2.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.7 | 12.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.7 | 7.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.7 | 2.8 | GO:0002046 | opsin binding(GO:0002046) |
0.7 | 4.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.7 | 6.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.7 | 2.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.7 | 2.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.7 | 11.7 | GO:0005112 | Notch binding(GO:0005112) |
0.7 | 2.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.7 | 2.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.6 | 3.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.6 | 3.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.6 | 1.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.6 | 4.5 | GO:0080014 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.6 | 1.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.6 | 1.8 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.6 | 1.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.6 | 11.9 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.6 | 7.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.6 | 1.8 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.6 | 9.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.6 | 6.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 0.6 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.6 | 1.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.6 | 2.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.6 | 1.7 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.5 | 2.2 | GO:0035276 | ethanol binding(GO:0035276) |
0.5 | 0.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.5 | 9.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.5 | 2.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.5 | 1.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 3.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.5 | 1.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.5 | 49.6 | GO:0019838 | growth factor binding(GO:0019838) |
0.5 | 3.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 12.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.5 | 2.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.5 | 3.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.5 | 1.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.5 | 9.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.5 | 3.6 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.5 | 0.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.5 | 2.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.5 | 2.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.5 | 1.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 1.5 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.5 | 1.0 | GO:0032564 | dATP binding(GO:0032564) |
0.5 | 1.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.5 | 3.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.5 | 13.4 | GO:0042805 | actinin binding(GO:0042805) |
0.5 | 1.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 3.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.5 | 1.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.5 | 0.5 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.5 | 2.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.5 | 1.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.5 | 8.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 5.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.4 | 4.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 4.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.4 | 1.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.4 | 2.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 5.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.4 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.4 | 0.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.4 | 2.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 3.3 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 1.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 1.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 2.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.4 | 2.0 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.4 | 1.6 | GO:0045340 | mercury ion binding(GO:0045340) |
0.4 | 2.0 | GO:0031432 | titin binding(GO:0031432) |
0.4 | 1.2 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.4 | 0.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 1.2 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.4 | 0.8 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.4 | 1.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.4 | 3.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 7.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 1.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.4 | 1.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.4 | 0.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.4 | 1.8 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.4 | 9.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.4 | 1.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 2.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.4 | 5.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.4 | 2.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 2.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.4 | 0.7 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.4 | 1.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.4 | 6.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 1.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 1.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 1.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 1.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.3 | 1.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.3 | 4.5 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.3 | 1.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 28.0 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 1.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 3.4 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.3 | 1.4 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.3 | 0.7 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.3 | 1.0 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 1.0 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.3 | 1.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 2.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 1.0 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 2.2 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.3 | 1.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 0.6 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.3 | 4.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 0.6 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.3 | 1.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.3 | 0.9 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.3 | 0.9 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.3 | 2.8 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.3 | 3.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 1.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 1.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 4.1 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.3 | 2.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 1.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 6.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 0.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 3.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 0.3 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.3 | 0.9 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 0.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 0.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.3 | 0.8 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 1.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 0.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 0.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 0.6 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 2.2 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.3 | 1.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.3 | 0.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 1.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.3 | 0.8 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.3 | 1.1 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 1.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 0.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.3 | 2.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.3 | 1.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 0.8 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.3 | 0.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 2.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 2.9 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 2.1 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.3 | 3.9 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 1.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 4.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.3 | 1.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.3 | 4.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 0.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 1.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 2.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 0.5 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.2 | 1.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 0.7 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 1.5 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 2.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 0.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 0.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 0.7 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 0.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 4.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 5.4 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 0.7 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.2 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 0.5 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 0.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 0.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 3.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 0.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 0.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 2.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 19.7 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.2 | 1.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 0.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 1.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.7 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 0.2 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 1.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 1.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 1.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.2 | 1.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 1.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 3.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 1.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 4.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.6 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.6 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 0.4 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 1.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 1.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 11.4 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 1.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 1.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 1.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.2 | 0.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 3.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 4.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 1.0 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 0.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 2.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.8 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 2.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 0.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 2.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 1.9 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 11.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.5 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 0.5 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 0.9 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 2.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 0.9 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 0.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 2.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 1.8 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 0.9 | GO:0030546 | receptor activator activity(GO:0030546) |
0.2 | 0.4 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.2 | 1.2 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 2.5 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 0.7 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 14.2 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 6.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 1.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 0.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 10.9 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 0.5 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 0.5 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.2 | 0.7 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.2 | 2.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.7 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 1.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 0.2 | GO:1901474 | L-histidine transmembrane transporter activity(GO:0005290) azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.2 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 0.3 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.2 | 0.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 0.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 4.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 1.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.8 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 1.7 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.2 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 0.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 0.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 0.8 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 2.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 0.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 1.0 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 1.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 2.2 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 2.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.4 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 0.7 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 2.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 1.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.1 | 0.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 24.3 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 1.8 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 1.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.3 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 3.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.8 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.4 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.5 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.3 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 0.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.0 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.6 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 1.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.9 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 4.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 0.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.5 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 1.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 4.8 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 1.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 1.0 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 0.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 1.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 2.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 6.3 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 2.7 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 1.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.3 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.1 | 1.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.9 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 16.7 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 1.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 3.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 1.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.3 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 0.5 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.1 | 2.9 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.1 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.1 | 0.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.6 | GO:0018449 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.9 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.7 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 8.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 3.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.6 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.2 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.2 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.9 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 0.6 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.1 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.3 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 1.7 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 1.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 0.5 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 3.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.2 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.1 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 1.3 | GO:0016684 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.9 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 1.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.3 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 1.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.6 | GO:0034783 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.3 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.5 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.1 | 0.2 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 5.6 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 1.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.1 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 10.3 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.1 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.1 | 0.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.5 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 1.9 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.7 | GO:0070636 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.2 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.1 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.1 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.1 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 1.0 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.2 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.4 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.3 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.6 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.2 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.0 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 3.6 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 20.0 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.0 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 1.7 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.2 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 1.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.7 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.5 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.0 | 0.1 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.0 | GO:0030351 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.0 | 10.6 | GO:0008134 | transcription factor binding(GO:0008134) |
0.0 | 0.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.4 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.5 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.1 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 4.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.0 | GO:0016418 | S-acetyltransferase activity(GO:0016418) dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.0 | 0.2 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.0 | 0.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.0 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 5.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 34.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.0 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.0 | 0.0 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.1 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.0 | 0.0 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.0 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.7 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.7 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.0 | 0.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.0 | 0.2 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.0 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.0 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 0.0 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.0 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.0 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.0 | 0.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.0 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.0 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.0 | 0.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.0 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.0 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.2 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.0 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.0 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.0 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.0 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.0 | 0.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 42.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.1 | 18.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.9 | 22.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.9 | 13.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.9 | 12.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.9 | 6.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.7 | 4.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.7 | 16.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.6 | 5.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.6 | 21.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.6 | 5.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.5 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 1.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.5 | 15.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.5 | 9.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.5 | 1.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.5 | 12.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 6.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 4.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 9.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 4.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.4 | 4.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 5.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 3.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.4 | 1.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.4 | 11.6 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.4 | 12.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 14.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.3 | 4.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 11.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 2.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 0.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 3.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 9.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 2.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 2.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 11.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.3 | 0.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 5.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 3.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.3 | 6.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 6.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 7.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.3 | 8.9 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 2.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 3.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 10.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 10.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 1.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 1.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 11.3 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 2.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 3.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 0.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 2.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 1.3 | PID ATM PATHWAY | ATM pathway |
0.2 | 0.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 0.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 1.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 2.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 8.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 1.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 2.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 2.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 2.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 1.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 3.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 5.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 1.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 4.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 1.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 2.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 0.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 0.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 2.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 2.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 2.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 3.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 1.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 23.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.1 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 3.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 4.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 13.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 3.8 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 10.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.2 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 2.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 1.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID BARD1 PATHWAY | BARD1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 1.9 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
1.5 | 31.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.9 | 12.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.9 | 11.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.8 | 8.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.8 | 22.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.8 | 7.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.7 | 7.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.7 | 7.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.7 | 12.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.7 | 20.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.7 | 2.1 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.7 | 7.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.7 | 5.9 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.6 | 6.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.6 | 5.7 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.6 | 14.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.6 | 10.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.6 | 11.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.6 | 12.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.6 | 5.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 9.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.5 | 6.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.5 | 1.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.5 | 4.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 7.5 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.4 | 8.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 7.6 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.4 | 2.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 3.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 15.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 7.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.4 | 0.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 3.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 1.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.4 | 3.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 2.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.4 | 3.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.4 | 2.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 1.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 2.7 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 5.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 2.6 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.3 | 2.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 4.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 0.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.3 | 3.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 2.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 0.5 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.3 | 3.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 3.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 5.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 2.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 7.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 6.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 1.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 2.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 1.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 0.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.2 | 0.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 6.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 2.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 1.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 1.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 3.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 2.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 2.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 1.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 1.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 0.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 3.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 3.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 1.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 8.4 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.2 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 1.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 2.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 1.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 1.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 4.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 14.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 3.2 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.2 | 4.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 3.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 2.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 6.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 2.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 1.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 2.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 13.7 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 5.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 3.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.3 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 0.8 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 1.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 2.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 1.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 3.7 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.1 | 0.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 11.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 4.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 1.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 0.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 1.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 7.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.8 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 0.3 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.1 | 8.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 2.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.3 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 0.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 1.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 2.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 2.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.2 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.1 | 1.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 3.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 0.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.4 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.2 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.1 | 1.0 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 1.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 8.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 0.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.4 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 2.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.1 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 4.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.4 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 1.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.0 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.0 | 1.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.8 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.0 | 0.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.0 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.1 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.3 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |